| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,335 |
5,305 |
$201K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,875 |
2,557 |
$103K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
377 |
355 |
$18K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,528 |
671 |
$16K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
152 |
146 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
607 |
288 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
87 |
83 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
81 |
79 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
259 |
226 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
59 |
58 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
113 |
111 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
31 |
28 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$942.91 |
| 90461 |
|
303 |
152 |
$880.78 |
| 90686 |
|
26 |
25 |
$129.15 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
38 |
30 |
$30.40 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$22.43 |
| 90710 |
|
29 |
28 |
$0.00 |
| 90633 |
|
16 |
15 |
$0.00 |
| 90715 |
|
14 |
13 |
$0.00 |
| 90670 |
|
26 |
24 |
$0.00 |
| 90734 |
|
17 |
16 |
$0.00 |